Ironwood Pharmaceuticals IRWD Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $296.15M-15.7% | $351.41M-20.6% | $442.74M+7.8% | $410.6M-0.8% | ||
| $95.14M-14.6% | $111.42M-4.0% | $116.09M+162% | $44.27M-37.1% | ||
| $82.26M-43.0% | $144.27M-8.9% | $158.31M+36.5% | $115.99M+4.4% | ||
| $197.65M-23.5% | $258.29M-81.4% | $1.39B+766% | $160.26M-11.7% | ||
| $98.5M+5.8% | $93.12M+109% | -$983.02M-493% | $250.34M+7.8% | ||
| 33.3%+6.8pp | 26.5%+249pp | -222%-283pp | 61%+4.8pp | ||
| $32.75M-0.9% | $33.03M+52.7% | $21.63M+185% | $7.6M-75.6% | ||
| -$28.48M-2.0% | -$27.93M-958% | -$2.64M-227% | $2.09M+107% | ||
| $70.03M+7.4% | $65.2M+107% | -$978.43M-488% | $252.42M+25.8% | ||
| $46.01M-28.5% | $64.32M-23.0% | $83.49M+7.9% | $77.36M+123% | ||
| $24.02M+2,629% | $880K+100% | -$1B-672% | $175.07M-66.9% | ||
| 8.1%+7.9pp | 0.3%+227pp | -226.4%-269pp | 42.6%-85.1pp | ||
| $0.13+1,400% | -$0.01+99.8% | -$6.51-771% | $0.97-70.0% | ||
| $100.38M+6.4% | $94.32M+110% | -$981.82M-490% | $251.74M+7.7% | ||
| 33.9%+7.1pp | 26.8%+249pp | -221.8%-283pp | 61.3%+4.8pp | ||
| $98.5M+5.8% | $93.12M+109% | -$983.02M-493% | $250.34M+7.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Ironwood Pharmaceuticals's revenue?
- Ironwood Pharmaceuticals (IRWD) generated $361.5M in revenue over the trailing twelve months, up 13.8% year over year.
- Is Ironwood Pharmaceuticals profitable?
- Ironwood Pharmaceuticals reported $102.2M in net income over the trailing twelve months, a 28.3% net margin.
- What are Ironwood Pharmaceuticals's profit margins?
- Gross margin is 99.2% and operating margin is 55.4%, with a 28.3% net margin.
- What is Ironwood Pharmaceuticals's earnings per share?
- Ironwood Pharmaceuticals's diluted EPS over the trailing twelve months is $0.60.
- Where does Ironwood Pharmaceuticals's income statement data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
